Document Detail


PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.
MedLine Citation:
PMID:  25300316     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Prescribed in patients with a history of myocardial infarction, stroke, transient ischemic attack, coronary intervention or bypass surgery, aspirin is one of the medications most commonly used in the secondary prevention of cardiovascular diseases. It has become a mainstay of therapy after years of solid evidence supporting its efficacy in clinical trials. However, a number of risks and side effects accompany its benefits, including the notable risk of bleeding and gastrointestinal side effects. Numerous mechanisms have been proposed to attenuate these effects to promote adherence and to expand the population for which aspirin is a reasonable treatment option. A polypill or combination formulation that includes a proton pump inhibitor, a drug commonly prescribed alongside aspirin, is one potential avenue of therapy. One such combination pill, PA32540, has undergone Phase I and Phase III trials and shows promising safety and efficacy results in these preliminary trials.
Authors:
Danielle Duffy; Bridget Rooney; Suzanne Adams; David J Whellan
Related Documents :
25230926 - Association of left atrial booster-pump function with heart failure symptoms in patient...
9345446 - Cardiovascular regulation in multiple sclerosis.
4008896 - Changes in ventricular fibrillation threshold with stimulation of cardiac sympathetic n...
19353696 - Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to incre...
10937926 - The influence of diastolic and systolic function on exercise performance in heart failu...
8269326 - Signal averaging in patients with coronary artery disease: how helpful is it?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-10
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  -     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-10     Completed Date:  -     Revised Date:  2014-10-11    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-10     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression banda...
Next Document:  Impact of pharmacy worker training and deployment on access to essential medicines and health outcom...